SMD Rise PCL (BKK:SMD100) Debt-to-EBITDA : 1.76 (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is SMD Rise PCL Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

SMD Rise PCL's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ฿209.3 Mil. SMD Rise PCL's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ฿66.5 Mil. SMD Rise PCL's annualized EBITDA for the quarter that ended in Dec. 2024 was ฿157.1 Mil. SMD Rise PCL's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2024 was 1.76.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for SMD Rise PCL's Debt-to-EBITDA or its related term are showing as below:

BKK:SMD100' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.13 Med: 0.88 Max: 2.71
Current: 2.71

During the past 7 years, the highest Debt-to-EBITDA Ratio of SMD Rise PCL was 2.71. The lowest was 0.13. And the median was 0.88.

BKK:SMD100's Debt-to-EBITDA is ranked worse than
53.49% of 86 companies
in the Medical Distribution industry
Industry Median: 2.57 vs BKK:SMD100: 2.71

SMD Rise PCL Debt-to-EBITDA Historical Data

The historical data trend for SMD Rise PCL's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SMD Rise PCL Debt-to-EBITDA Chart

SMD Rise PCL Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Debt-to-EBITDA

Get a 7-Day Free Trial

2.17

0.65

0.13

0.38

2.71

SMD Rise PCL Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Debt-to-EBITDA	Get a 7-Day Free Trial															0.27	-5.28	2.38	0.99	1.76

Competitive Comparison of SMD Rise PCL's Debt-to-EBITDA

For the Medical Distribution subindustry, SMD Rise PCL's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SMD Rise PCL's Debt-to-EBITDA Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, SMD Rise PCL's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where SMD Rise PCL's Debt-to-EBITDA falls into.

Save Embed

;

Save Embed

;

SMD Rise PCL Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

SMD Rise PCL's Debt-to-EBITDA for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(209.257	+	66.524)	/	101.928
	=	2.71

SMD Rise PCL's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2024 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(209.257	+	66.524)	/	157.092
	=	1.76

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2024) EBITDA data.

SMD Rise PCL (BKK:SMD100) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

SMD Rise PCL Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of SMD Rise PCL's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

SMD Rise PCL Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » SMD Rise PCL (BKK:SMD100) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

222,222/1-2 Moo 1, Rattanathibet Road, West Inn Complex Building, 10th Floor, Bang Rak Yai Subdistrict, Bang Bua Thong District, Nonthaburi Province, Bangkok, THA, 11110

Website

https://www.saintmed.com

SMD Rise PCL, formerly Saintmed PCL is engaged in the import and distribution of medical devices and equipment, rental services for medical equipment, and providing services related to medical equipment. It operates in Thailand. The Group is engaged in two operating segments which are, the distribution of medical device and equipment, medical supply and providing medical equipment services, share service, and other services.

SMD Rise PCL Headlines

No Headlines